| abstract |
In various aspects and embodiments, methods are provided for treating an age-related disease or disorder in a patient and/or treating or preventing frailty in a patient. In certain embodiments, the methods comprise administering a recombinant TLR5 agonist (e.g., a flagellin-based agent). |